SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
chronic myeloid leukemia
Journals
11
1
European journal of medicinal chemistry
2
Scientific reports
3
Cureus
4
bratislavske lekarske listy
5
journal of clinical oncology : official journal of the american society of clinical oncology
6
clinical lymphoma, myeloma & leukemia
7
hospitals
8
Therapeutic advances in hematology
9
Annals of hematology
10
problemy radiatsiinoi medytsyny ta radiobiolohii
11
journal of the optical society of america
Research Groups
0
No Research Group Connected
Bibliographies
38
1
The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 Recommendations.
2
Radotinib and its clinical potential in chronic-phase chronic myeloid leukemia patients: an update.
3
Сase Report of Acute Toxic Imatinib-induced Hepatitis in a Patient with Chronic Myeloid Leukemia, Sulfa Allergy, and Rheumatoid Arthritis.
4
Evaluation of cardiovascular ischemic event rates in dasatinib-treated patients using standardized incidence ratios.
5
Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.
6
Nitrification inhibitors can increase post-harvest nitrous oxide emissions in an intensive vegetable production system.
7
Assessment of response to imatinib therapy in patients with chronic myeloid leukemia with e13a2 and e14a2 transcripts of BCR/ABL1 gene.
8
A visual system model and a new distortion measure in the context of image processing.
9
Drug distribution in hospitals. Unit-dose systems reduce error, increase efficeincy.
10
Identification and development of non-cytotoxic cell death modulators: Impact of sartans and derivatives on PPARγ activation and on growth of imatinib-resistant chronic myelogenous leukemia cells.
11
MicroRNAs expression profiles as biomarkers and therapeutic tools in Turkish patients with chronic myeloid leukemia.
12
leucemia mielóide crônica: novas drogas em desenvolvimento chronic myeloid leukemia: development of new drugs
13
trisomy of chromosome 8 in ph-negative cells of the bone marrow in patients with chronic myeloid leukemia treated with inhibitors of bcr-abl tyrosinkinases
14
a rare presentation of chronic myeloid leukemia blast crisis
15
treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
16
monitoramento de doença residual mínima em leucemia mielóide crônica por pcr em tempo real monitoring minimal residual disease in chronic myeloid leukemia by real time pcr
17
low body weight and body mass index may be associated with musculoskeletal pain following imatinib discontinuation in chronic myeloid leukemia
18
Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec.
19
Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes
20
Clinical classification of 109 chronic myeloid leukemia cases and its correlation with Ph chromosomes.
21
Listeria monocytogenes Meningitis Following Imatinib Mesylate-Induced Monocytopenia in a Patient with Chronic Myeloid Leukemia
22
Philadelphia-negative acute promyelocytic leukemia in a patient with chronic myeloid leukemia in complete cytogenetic response after treatment with tyrosine kinase inhibitor
23
a case of chronic myeloid leukemia in a patient of double heterozygous hb-e beta thalassemia
24
development and targeted use of nilotinib in chronic myeloid leukemia
25
adherence to treatment with imatinib in chronic myeloid leukemia: a study of the first decade of responses obtained at a brazilian hospital
26
vertigo as the first sign of chronic myeloid leukemia: a case report and literature review
27
metilação e expressão do gene junb na leucemia mieloide crônica junb methylation and expression in chronic myeloid leukemia
28
importance of monitoring and early switch to second generation tyrosine kinase inhibitors for the prognosis of patients with chronic myeloid leukemia with imatinib resistance or intolerance
29
Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2
30
concomitant chronic myeloid leukemia and monoclonal b cell lymphocytosis - a very rare condition
31
determinants of overall and progression-free survival of nigerian patients with philadelphia-positive chronic myeloid leukemia
32
emerging therapeutic strategies for targeting chronic myeloid leukemia stem cells
33
successful peripheral blood stem cells collection in imatinib pretreated and nilotinib-treated chronic myeloid leukemia patient
34
bilateral hip pain caused by adductor pyomyositis as the initial presentation of chronic myeloid leukemia in a 17-year-old child
35
monitoração molecular da leucemia mielóide crônica na era do imatinibe molecular monitoring of chronic myeloid leukemia in the imatinib era
36
Treatment of Ph+ chronic myeloid leukemia by gamma interferon
37
[Clinical Retrospective Analysis of Chronic Myeloid Leukemia in Myeloid Blast Crisis].
38
Platelet Dysfunction in Patients with Chronic Myeloid Leukemia: Does Imatinib Mesylate Improve It?